Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma

Sarcoma patients with a PRO circulating T cell immunotype had inferior outcomes to ICB, while those with an immune-enriched/non-fibrotic TME had superior outcomes. Automated analysis of H&E slides showed promise in identifying patients with an immune-enriched TME. These findings support utilization of a multimodal approach toward identifying predictors of response to immunotherapy in sarcoma.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-12
DOI
https://doi.org/10.1158/1078-0432.ccr-25-3419
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma

Jasme Lee, Paige Fuentes, Mohammad Yosofvand, A. Subramanian et al.
Clinical Cancer Research
Cancer Immunotherapy and Biomarkers
article

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma

Jasme Lee, Paige Fuentes, Mohammad Yosofvand, A. Subramanian, Paige Collins, Lauren B. Banks, Ping Chi, Everett J. Moding, Damon R. Reed, О. Yu. Baranov, Mrinal M. Gounder, K. Panageas, Jason E. Chan, Mark A. Dickson, Evan Rosenbaum, W. Tap, Martina Bradić, Sujana Movva, Allison Reiner, Konstantin Chernyshov, Mathew Adamow, Sandra P. D’Angelo, Nikita Kotlov, Fiona Ehrich, Rhoena Desir, Mary Lou Keohan, C. Antonescu, Phillip Wong, Li-Xuan Qin, Viswatej Avutu, Ciara M. Kelly
article en

Abstract

Sarcoma patients with a PRO circulating T cell immunotype had inferior outcomes to ICB, while those with an immune-enriched/non-fibrotic TME had superior outcomes. Automated analysis of H&E slides showed promise in identifying patients with an immune-enriched TME. These findings support utilization of a multimodal approach toward identifying predictors of response to immunotherapy in sarcoma.

Clinical Cancer Research
Memorial Sloan Kettering Cancer Center (US), Cornell University (US), Stanford Medicine (US), Repligen (United States) (US)
Openalex Percentile: Top 58%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.